Fee-Way Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Bareilly, Uttar Pradesh, India, established in 2021.
2021 Bareilly, Uttar Pradesh, India Active
Last Updated:
Access Report
About Fee-Way Pharmaceuticals Private Limited

Fee-Way Pharmaceuticals Private Limited, a active private limited company, was established on 11 November 2021 in Bareilly, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24299UP2021PTC155278. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rajeev Kumar Sharma (Director), Rohit Sharma (Director). Past directors included Mohd Shoaib, Mohd Irfan Ansari. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Faryad S/O Mohd Firaset Chetna Colony, Nakatiya, Bareilly, Uttar Pradesh, 243123.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299UP2021PTC155278

  • Registration Number

    155278

  • Incorporation Date

    11 November 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Fee-Way Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fee-Way Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Fee-Way Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajeev Kumar Sharma Director 09 Nov 2023 Current
Rohit Sharma Director 11 Nov 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Nov 2023 Past
Pramod Abcsdd Director 09 Nov 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fee-Way Pharmaceuticals.

Enhance accessibility to Fee-Way Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Fee-Way Pharmaceuticals revenue growth over time
Fee-Way Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fee-Way Pharmaceuticals?

Unlock access to Fee-Way Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Fee-Way Pharmaceuticals?

Fee-Way Pharmaceuticals has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fee-Way Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fee-Way Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fee-Way Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Fee-Way Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Fee-Way Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.

  • Director Appointment

    The activity Rajeev Kumar Sharma was appointed as a Director was appointed as a Director on 09 Nov 2023 & has been associated with this company since 2 years 3 months . was completed.

  • Director Appointment

    Progress on Rohit Sharma was appointed as a Director was appointed as a Director on 11 Nov 2021 & has been associated with this company since 4 years 3 months . was documented.

  • Company Incorporation

    The activity Fee-Way Pharmaceuticals Private Limited was registered on 11 Nov 2021 with Roc Kanpur & aged 4 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Fee-Way Pharmaceuticals Private Limited?

The CIN of Fee-Way Pharmaceuticals Private Limited is U24299UP2021PTC155278.

Where is Fee-Way Pharmaceuticals Private Limited headquartered?

Fee-Way Pharmaceuticals Private Limited is headquartered at C/O Faryad S/O Mohd Firaset Chetna Colony, Nakatiya, Bareilly, Uttar Pradesh, 243123.

When was Fee-Way Pharmaceuticals Private Limited incorporated?

Fee-Way Pharmaceuticals Private Limited was incorporated on 11 November 2021.

Who are the current directors of Fee-Way Pharmaceuticals Private Limited?

The current directors of Fee-Way Pharmaceuticals Private Limited are

What is the primary industry of Fee-Way Pharmaceuticals Private Limited?

The primary industry of Fee-Way Pharmaceuticals Private Limited is Chemicals.

Is Fee-Way Pharmaceuticals Private Limited a listed company?

Fee-Way Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Fee-Way Pharmaceuticals Private Limited?

The authorized capital of Fee-Way Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available